Logo

Proteins Don't Belong to Companies

Aug 01, 2008

The UK's High Court revoked Human Genome Sciences' patent on neutrokine-alpha, a protein involved in a number of inflammatory diseases, such as arthritis, asthma and chronic pulmonary disease, says the Financial Times. The judge ruled that HGS never said what the protein did or how it would function as a drug target in its initial application, according to the article, which also hints that HGS will have to scramble in its ongoing collaboration with GSK on a neutrokine-alpha drug for rheumatoid arthritis and lupus.

Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.